News
Dr Harsh Vardhan updates on biotechnology/S&T Parks at Lok Sabha meeting
These Biotechnology Parks offer facilities to scientists, and Small and Medium sized Enterprises (SMEs) for technology incubationand pilot plant studies for accelerated commercial development of biotechnology products.
Biocon and Mylan launch Biosimilar Pegfilgrastim in Australia
India’s leading BioPharma company Biocon Ltd and Mylan N.V. announced the launch of Fulphila in Australion. Fulphila is a biosimilar to Neulasta (pegfilgrastim) and is available on the Pharmaceutical Benefits Scheme (PBS).
WHO Director-General declares COVID-19 as Pandemic infection
Although WHO says that it has been assessing this outbreak around the clock, the organization is deeply concerned both by the alarming levels of spread and severity, and by the alarming levels of inaction.
Vir Biotechnology collaborates National Institutes of Health Vaccine Research Center on antibodies against Coronaviruses
Vir and NIAID will work together to identify and optimize combinations of antibodies against coronaviruses, including SARS-CoV-2, SARS and MERS.
voice for BT and BEST 2026
